MOLN
Molecular Partners Ag -adr
$4.14
Earnings Summary
Revenue | $0.42Mn |
Net Profits | $-15.99Mn |
Net Profit Margins | -3852.29% |
Highlights
Molecular Partners Ag -adr’s revenue fell -96.47% since last year same period to $0.42Mn in the Q2 2023. On a quarterly growth basis, Molecular Partners Ag -adr has generated -94.88% fall in its revenue since last 3-months.
Molecular Partners Ag -adr’s net profit fell -253.54% since last year same period to $-15.99Mn in the Q2 2023. On a quarterly growth basis, Molecular Partners Ag -adr has generated -995.44% fall in its net profits since last 3-months.
Molecular Partners Ag -adr’s net profit margin fell -9908.11% since last year same period to -3852.29% in the Q2 2023. On a quarterly growth basis, Molecular Partners Ag -adr has generated -17586.81% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Molecular Partners Ag -adr post its latest quarter earnings
EPS Estimate Current Quarter | 0 |
EPS Estimate Current Year | 0 |
Highlights
Molecular Partners Ag -adr’s earning per share (EPS) estimates for the current quarter stand at 0 - a 100% jump from last quarter’s estimates.
Molecular Partners Ag -adr’s earning per share (EPS) estimates for the current year stand at 0.
Key Ratios
Key ratios of the Molecular Partners Ag -adr post its Q3 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Molecular Partners Ag -adr’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2023. This indicates that the Molecular Partners Ag -adr has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-10-26 | 0 | 0 | NaN% |
2023-04-10 | 0 | 0 | NaN% |
₹0 US Stocks a/c Opening Fee